Clinical trial

Role of Immunoglobulin in Male Infertility

Name

102023

Description

to investigate the role of IVIG in male infertility and to determine its benefits in term of semen parameters and assisted reproduction outcome

Trial arms

Trial start

2023-04-01

Estimated PCD

2024-06-01

Trial end

2024-12-01

Status

Recruiting

Treatment

IVIG

treatment of subfertility

Arms:

male fertility

Other names:

pentaglobin

Size

Primary endpoint

Semen parameters percentage improvement

6 month

Sperm motility

6 month

Sperm morphology

6 month

Eligibility criteria

Inclusion Criteria: * male patients Exclusion Criteria: * female

Protocol

{'studyType': 'INTERVENTIONAL', 'phases': ['NA'], 'designInfo': {'allocation': 'NA', 'interventionModel': 'SINGLE_GROUP', 'primaryPurpose': 'OTHER', 'maskingInfo': {'masking': 'NONE'}}, 'enrollmentInfo': {'count': 50, 'type': 'ESTIMATED'}}

Updated at

2024-05-21

1 organization

1 drug

1 indication

Organization

Dr Salma Kafeel Qureshi

Drug

IVIG

Indication

Male Infertility